> What HIPEC (hyperthermic intraperitoneal chemotherapy) is, when it is indicated and why it is combined with cytoreductive surgery. 3,000+ procedures.

**Fuente:** https://quenet-torrent.com/en/procedures/hipec/

---

Reviewed by [Dr. Juan José Torrent](https://quenet-torrent.com/en/our-team/juan-jose-torrent/) · Updated: July 29, 2026

# HIPEC: Hyperthermic Intraperitoneal Chemotherapy

Specialized procedure

Combined treatment of cytoreductive surgery and heated intra-abdominal chemotherapy for the treatment of peritoneal carcinomatosis with curative intent.

EXPLANATORY VIDEO

## Which cases need HIPEC?

Dr. Torrent explains which patients are candidates for HIPEC treatment and which selection criteria are applied in [peritoneal carcinomatosis](https://quenet-torrent.com/en/pathologies/peritoneal-carcinomatosis/). Video in Spanish.

-   Specific indications for the HIPEC procedure
-   Types of tumors that benefit from the treatment
-   Candidate selection criteria

## What is HIPEC?

**HIPEC** (Hyperthermic Intraperitoneal Chemotherapy) is a procedure that combines cytoreductive surgery with the direct application of heated chemotherapy inside the abdominal cavity. It is used to treat tumors that have spread to the peritoneum (peritoneal carcinomatosis).

The goal is to remove all visible tumor implants through surgery and then apply chemotherapy at a high temperature to destroy the residual microscopic cancer cells. Hyperthermia (heat) enhances the effect of chemotherapy drugs.

## How is the HIPEC procedure performed?

The HIPEC procedure is performed in the operating room under general anesthesia and consists of several phases:

![Operating room with advanced monitoring where the Quenet-Torrent team performs the HIPEC procedure with thermal control of the perfusion](https://quenet-torrent.com/img/fotos-hospital/quirofano-monitores.webp)

### 1\. Surgical exploration

Complete evaluation of the abdominal cavity to determine the extent of the disease and calculate the Peritoneal Cancer Index (PCI).

### 2\. Complete cytoreduction

Removal of all visible tumor implants, including peritonectomies and resection of affected organs if necessary.

### 3\. HIPEC application

Perfusion of the abdominal cavity with chemotherapy heated to 41-43°C for 30 to 90 minutes, ensuring contact with all peritoneal surfaces.

### 4\. Reconstruction

Intestinal anastomoses are performed and the abdominal cavity is closed after the chemotherapy solution has been drained.

## When is HIPEC indicated?

HIPEC is especially indicated for the following tumors with peritoneal involvement:

### Pseudomyxoma peritonei

Mucinous appendiceal tumors with peritoneal spread. This is the indication with the best results, with long-term survival rates above 80%.

### Peritoneal mesothelioma

Primary tumor of the peritoneum in which HIPEC has shown a significant survival benefit when complete cytoreduction is achieved.

### Ovarian cancer

HIPEC has shown benefit in advanced [ovarian cancer](https://quenet-torrent.com/en/pathologies/gynecological-tumors/ovarian-cancer/), especially in the setting of interval surgery after neoadjuvant chemotherapy.

### Colorectal carcinomatosis

In selected cases of carcinomatosis of colorectal origin with low tumor burden and favorable biology.

## Benefits of HIPEC treatment

These are the advantages of HIPEC in the treatment of peritoneal carcinomatosis:

### Intensive local treatment

Chemotherapy is delivered directly where the disease is, reaching concentrations up to 20 times higher than those of systemic chemotherapy.

### Lower systemic toxicity

Because it is applied locally, systemic side effects are fewer than with conventional intravenous chemotherapy.

### Synergistic effect of heat

Hyperthermia increases the penetration and effectiveness of chemotherapy drugs in tumor tissue.

### Curative potential

In selected indications, HIPEC offers the possibility of cure to patients who previously only had palliative options.

EXPLANATORY VIDEO

## Cytoreductive surgery plus HIPEC, step by step

Dr. Juan José Torrent Correa explains how HIPEC fits into a multidisciplinary strategy that combines systemic treatment, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Video in Spanish.

-   What the surgery aims for and what the subsequent perfusion adds
-   Why complete cytoreduction determines the outcome
-   The weight of patient selection and team experience

## HIPEC drugs and protocols

There is no single HIPEC protocol. The drug, dose, temperature and duration of the perfusion vary according to the origin of the tumor, the treatments received beforehand and the center's protocol.

### Mitomycin C

It is the preferred agent in the Peritoneal Surface Oncology Group International recommendations for peritoneal disease of colorectal and appendiceal origin, in longer perfusions.

### Oxaliplatin

Used in a short-course regimen. This is the protocol assessed in the PRODIGE 7 trial, which showed no overall survival benefit in disease of colorectal origin. It is also the drug we use in the two-stage treatment of [pseudomyxoma peritonei](https://quenet-torrent.com/en/pathologies/peritoneal-carcinomatosis/pseudomyxoma-peritonei/).

### Cisplatin

Commonly used in carcinomatosis of ovarian origin and in [peritoneal mesothelioma](https://quenet-torrent.com/en/pathologies/peritoneal-carcinomatosis/peritoneal-mesothelioma/). In peritoneal mesothelioma and in gastric cancer it is combined with adriamycin (doxorubicin).

### Temperature and duration

The perfusion is kept between 41 and 43 °C for 30 to 90 minutes depending on the protocol, with continuous thermal control and even distribution throughout the cavity.

## What the scientific evidence says about HIPEC

The **PRODIGE 7** trial, led by [Dr. François Quénet](https://quenet-torrent.com/en/our-team/francois-quenet/) and published in _The Lancet Oncology_, compared cytoreductive surgery alone with cytoreduction plus short-course oxaliplatin HIPEC in peritoneal metastases of colorectal origin. With that protocol, HIPEC **did not increase overall survival** and was associated with more late postoperative complications.

This result needs to be explained properly, because it is often misread. Both groups in the study exceeded 40 months of median survival, well above what would be expected with systemic treatment alone. What sustains that result is **complete cytoreduction**. HIPEC is an adjunct whose indication depends on the case, not a universal requirement or the element that defines the prognosis.

An international analysis published in _BJS Open_ in 2024, covering more than 2,000 patients, observed differing results across HIPEC regimens and, because of its retrospective design, could not establish that any of them was superior. That is why we indicate HIPEC on an individual basis, not automatically, and always after assessment by a multidisciplinary board.

## Recovery after HIPEC and possible complications

The operation usually lasts between 6 and 12 hours in a single surgical procedure. Depending on its extent, the first hours may be spent in the intensive care unit, and the hospital stay is roughly **7 to 14 days**.

After discharge, several weeks are usually needed to regain strength, appetite and usual activity. Like any major abdominal surgery, it carries risks that should be known before deciding: infection, bleeding, respiratory complications, thrombosis, impaired kidney function, delayed return of bowel transit, healing problems at the digestive anastomoses and toxicity from the drug used in the perfusion.

Case volume and team experience are consistently associated with lower rates of severe complications. You can find more detail in our article on the [side effects of HIPEC](https://quenet-torrent.com/en/blog/efectos-secundarios-hipec/).

## Our experience in HIPEC

At **Quenet-Torrent Institute** we focus on cytoreductive surgery and HIPEC. Our team has performed more than 3,000 HIPEC procedures, with oncological results published in high-impact scientific journals.

We work in a multidisciplinary environment that includes medical oncologists, radiologists, specialized anesthesiologists and nursing staff with specific training in this complex procedure.

![Entrance hall of Memorial Publio Cordón Hospital, where the Quenet-Torrent team sees patients who are candidates for HIPEC](https://quenet-torrent.com/img/hospital/hospital-hold.webp)

## Pathologies treated with HIPEC

The HIPEC procedure is used in the treatment of various pathologies with peritoneal involvement.

### Peritoneal carcinomatosis

Treatment of peritoneal tumor spread from various origins.

[More information about peritoneal carcinomatosis](https://quenet-torrent.com/pathologies/peritoneal-carcinomatosis/)

### Gynecological tumors

Especially indicated in advanced ovarian cancer with carcinomatosis.

[More information about gynecological tumors](https://quenet-torrent.com/pathologies/gynecological-tumors/)

### Colorectal tumors

In selected cases of carcinomatosis of colorectal origin.

[More information about colorectal tumors](https://quenet-torrent.com/pathologies/colorectal-tumors/)

## Frequently asked questions about HIPEC

Answers to the most common questions about the procedure, its indication and recovery.

### What is the HIPEC technique?

It is the delivery of heated chemotherapy, at 41 to 43 °C, inside the abdomen at the end of cytoreductive surgery. First all visible tumor implants are removed, and then the drug is circulated through the abdominal cavity for 30 to 90 minutes so that it acts on any microscopic disease that may remain.

### Are cytoreduction and HIPEC the same treatment?

No. **Cytoreduction** is the surgery that removes all visible tumor implants. **HIPEC** is the heated chemotherapy perfusion delivered afterwards inside the abdomen, aimed at the residual microscopic disease. They are two distinct phases of the same operation.

### Is HIPEC always given after cytoreduction?

No. It depends on the origin of the tumor, the available protocol, previous treatments and the board's assessment. The PRODIGE 7 trial showed that, in disease of colorectal origin with short-course oxaliplatin, adding HIPEC did not improve overall survival. What matters is achieving a complete cytoreduction.

### Does HIPEC replace intravenous chemotherapy?

No. HIPEC acts only inside the abdominal cavity. Intravenous chemotherapy reaches the whole body, including any disease that may exist outside the peritoneum. They are complementary and are usually combined within the same strategy, with systemic chemotherapy before or after surgery depending on the case.

### Why is the chemotherapy heated?

Hyperthermia, between 41 and 43 °C, enhances the cytotoxic effect of the drugs and improves their penetration into tissue. That penetration is estimated at a few millimeters, and this limited depth explains why HIPEC only makes sense when surgery has left minimal or no residual tumor.

### Which chemotherapy is used in HIPEC?

Mainly mitomycin C, oxaliplatin and cisplatin, depending on the origin of the tumor. Mitomycin C is preferred in international recommendations for colorectal and appendiceal origin. Cisplatin is used more in ovarian origin and in peritoneal mesothelioma, where it is combined with doxorubicin, as it is in gastric cancer.

### How long does the operation take?

Usually between 6 and 12 hours, in a single surgical procedure under general anesthesia. The HIPEC perfusion takes 30 to 90 minutes of that time, depending on the protocol and the drug used. The rest is the cytoreduction, whose duration depends on the extent of the disease.

### How long are the hospital stay and recovery?

The hospital stay is roughly 7 to 14 days, with an initial period in intensive care depending on the extent of the surgery. After discharge, several weeks are usually needed to regain strength, appetite and usual activity. Enhanced recovery protocols shorten both periods.

### What are the side effects of HIPEC?

Those of any major abdominal surgery, plus the toxicity of the perfused drug. The main ones are infection, bleeding, respiratory complications, thrombosis, kidney problems, delayed bowel transit and healing problems at the digestive anastomoses. The center's case volume is associated with fewer severe complications.

### What is the life expectancy after HIPEC?

It depends mainly on where the tumor started and on whether cytoreduction was complete. In mucinous appendiceal tumors, long-term survival exceeds 80%. In the PRODIGE 7 trial, on peritoneal metastases of colorectal origin, patients exceeded 40 months of median survival both with and without HIPEC. In stage III ovarian cancer, the OVHIPEC trial recorded a median survival of 45.7 months with HIPEC compared with 33.9 months with surgery alone. These are figures for groups of patients; the prognosis of each case is assessed in consultation.

### What is the Peritoneal Cancer Index (PCI)?

It is the scale that measures the extent of the disease. It divides the abdomen into 13 regions and scores the size of the implants in each one from 0 to 3, up to 39 points. No figure automatically indicates or rules out surgery: the location of the implants matters as much as the total score.

### What happens if HIPEC cannot be given?

When a complete cytoreduction is not possible, the goal becomes controlling the disease. In selected cases [PIPAC](https://quenet-torrent.com/procedures/pipac/) may be considered: pressurized aerosol chemotherapy given by laparoscopy, repeatable over several sessions and especially useful for controlling ascites.
